PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations-Reference-Cited by-同舟云学术

PET/MRI versus PET/CT in oncology: a prospective single-center study of 330 examinations focusing on implications for patient management and cost considerations

Published:2019-08-13 Issue:1 Volume:47 Page:51-60
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Mayerhoefer Marius E.^ORCID,Prosch Helmut,Beer Lucian,Tamandl Dietmar,Beyer Thomas,Hoeller Christoph,Berzaczy Dominik,Raderer Markus,Preusser Matthias,Hochmair Maximilian,Kiesewetter Barbara,Scheuba Christian,Ba-Ssalamah Ahmed,Karanikas Georgios,Kesselbacher Julia,Prager Gerald,Dieckmann Karin,Polterauer Stephan,Weber Michael,Rausch Ivo,Brauner Bernhard,Eidherr Harald,Wadsak Wolfgang,Haug Alexander R.

Funder

Austrian Science Fund

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-019-04452-y.pdf

Reference34 articles.

1. Fendler WP, Czernin J, Herrmann K, et al. Variations in PET/MRI operations: results from an international survey among 39 active sites. J Nucl Med. 2016;57:2016–21.

2. Ishii S, Shimao D, Hara T, et al. Comparison of integrated whole-body PET/MR and PET/CT: is PET/MR alternative to PET/CT in routine clinical oncology? Ann Nucl Med. 2016;30:225–33.

3. Eiber M, Rauscher I, Souvatzoglou M, et al. Prospective head-to-head comparison of (11)C-choline-PET/MR and (11)C-choline-PET/CT for restaging of biochemical recurrent prostate cancer. Eur J Nucl Med Mol Imaging. 2017;44:2179–88.